Research suggests music therapy alongside usual substance-use care may help with craving and treatment motivation, but confidence varies across reviews. A later review rated that evidence lower than the 2022 Cochrane review. These findings do not establish long-term recovery benefits or validate a particular provider’s music-assisted program. The activity, comparison, outcome and timing need to match the claim.
A program’s use of music deserves a more specific inquiry than whether instruments are available. Ask what the activity is intended to do, who guides it and how it connects with the rest of care. This article reviews published evidence and terminology; it does not report an interview or a visit.
What the research supports
A 2022 Cochrane review included 21 studies with 1,984 participants. It found probable benefits for craving and treatment motivation when music therapy was added to usual care. It found no clear benefit for anxiety or depression and no meaningful effect on retention. Confidence varied; many studies came from the same researcher and detoxification unit, limiting transfer to other settings.
What later research adds
A review of reviews in BJPsych Open’s 2025 volume reused the Ghetti review for substance-use disorders and recalculated its underlying data. It rated the craving evidence very low certainty and treatment-motivation evidence low certainty. Its search for reviews ended February 20, 2023. This is a later assessment of overlapping evidence, not a new set of addiction-treatment patients or independent replication.
The difference in confidence matters. A reader should not combine two reviews of the same studies as though twice as many people had been studied. The cautious conclusion is that the approach warrants specific discussion within care, while the strength and transferability of the evidence remain limited. We have not independently recalculated either review or adjudicated their certainty ratings.
Two 2024 publications answer narrower questions. A Norwegian interview study by Ghetti and colleagues explored eight adults’ experiences of music and music therapy alongside substance-use and ADHD-related challenges. Themes included motivation, mastery and social belonging. These are rich accounts of experience, not a controlled estimate of treatment effectiveness.
A trial by Silverman, reported in a 2024 journal issue compared lyric analysis, recreational music therapy and songwriting among 103 adults in inpatient detoxification. Its single-session, pre/post measures concerned group relationships. The author’s university abstract reports differences between conditions; we did not access the full paper. This does not test music against no music or establish a lasting substance-use outcome.
| Evidence type | What to keep attached to the finding |
|---|---|
| A review of controlled trials | Retain the actual comparator, outcome and certainty; check whether later reviews reuse those trials. |
| Participant interviews | Use them to understand the reported experience and its context; do not convert themes into a success rate. |
| A comparison of music activities | Retain the particular activities, session duration and relationship measure; do not substitute a long-term recovery claim. |
These selected publications add context to the earlier review. They were found in a targeted search on September 8, 2026; this article is not a systematic update of all subsequent music research. A 2025 publication date, for example, need not mean a review searched through 2025.
Music therapy and music-assisted care
The American Music Therapy Association defines music therapy around individualized clinical goals, a therapeutic relationship, and a professional with approved training and credentials. That is more specific than having music available during a program.
When comparing services, ask what terminology the program uses. A music-based activity, a session with a credentialed music therapist, and a broader treatment philosophy may describe different experiences. The name alone does not answer who leads a session or what its purpose is.
A provider example: terminology matters
In its published treatment FAQ, Recovery Unplugged describes music-assisted treatment as a way to use people’s emotional connection with music to help them engage with traditional treatment. The organization says music appreciation and engagement run through its care model, rather than describing its service as music therapy alone.
That emphasis makes engagement a useful starting point for an inquiry. Ask how music is integrated into the specific program you are considering, how the team adapts it to a person’s preferences, and how it sits alongside the other services in that location. These are questions about the actual experience of care, beyond the presence of a guitar or a playlist.
How to read a program’s claim
A published study and a program description answer different questions. The study can inform an explanation of an intervention in a defined population. The description tells you what an organization says it offers. To connect them, ask whether the people, intervention, comparison and outcome match. The table is an original editorial reading aid, not a clinical rating.
| Check | Question to ask |
|---|---|
| People and setting | Does the evidence concern people with the same type of concern and a comparable treatment setting? |
| Actual intervention | Was the studied activity led by a trained music therapist, and is that what this program offers? |
| Comparison | Was music added to usual care, compared with another activity, or tested as a substitute? |
| Outcome and timing | Was the result craving, motivation, attendance or substance use? When was it measured? |
Consider a fictional advertisement that cites “better motivation” and then promises “lasting recovery.” The second phrase needs its own evidence; changing the outcome changes the claim. Ask for the study and the result that supports the promise. This example is not an allegation about a named provider.
Similarly, a participant’s account of finding a session meaningful can describe that person’s experience without proving an effect for everyone. Keep experience, program practice and research findings distinct. A useful conversation with the team can explore all three without treating them as interchangeable.
What this evidence leaves unanswered
The review reported no adverse-event data; that does not prove universal suitability. Ask how the team adapts participation when music feels uncomfortable and how concerns are raised.
Cochrane’s search ended in February 2021. The later publications discussed above have their own study designs and evidence dates. We have not established the latest possible trial or a complete inventory of harms. This article’s update date does not make the underlying observations newer.
Questions that make the approach concrete
- Who leads the music sessions, and what training and credentials do they have?
- What would a typical week include at the location I am considering?
- How are the activities connected to my care plan and the goals discussed with the clinical team?
- Can activities be adapted if I do not play an instrument, do not want to perform, or find particular music uncomfortable?
- How does the team check whether this part of care is useful to me?
You do not have to settle those questions by yourself before reaching out. Bring them to the program and ask for specific answers. Our first-conversation guide offers a way to organize what you want to discuss.
For a broader way to check a percentage, follow-up claim or testimonial, read how to read a treatment outcome claim.
Read more about finding care
Use our program comparison guide to organize questions about a service, or browse the local desk for public resources and regional guides.
This feature is a synthesis of published research and the provider’s description. It does not report an interview or a visit to a facility. No named clinician has reviewed this feature. Original terminology and provider sources were checked September 7, 2026; the research review and added publications were checked September 8, 2026. The Silverman paper was read at abstract level. No provider’s outcomes were independently verified.